The type 4 cAMP-specific phosphodiesterases (PDE4s) are Mg2+-dependent hydr
olases that catalyze the hydrolysis of 3',5'-cAMP to AMP. Previous studies
indicate that PDE4 exists in two conformations that bind the inhibitor roli
pram with affinities differing by more than 100-fold. Here we report that t
hese two conformations are the consequence of PDE4 binding to its metal cof
actor such as Mg2+. Using a fluorescence resonance energy transfer (FRET)-b
ased equilibrium binding assay, we identified that L-791,760, a fluorescent
inhibitor, binds to the apoenzyme (free enzyme) and the holoenzyme (enzyme
bound to Mg2+) With comparable affinities (K-d similar to 30 nM). By measu
ring the displacement of the bound L-791,760, we have also identified that
other inhibitors bind differentially with the apoenzyme and the holoenzyme
depending upon their structure. CDP-840, SB-207499, and RP-73401 bind prefe
rentially to the holoenzyme. The conformational-sensitive inhibitor (R)-rol
ipram binds to the holoenzyme and apoenzyme with affinities (K-d) of 5 and
300 nM, respectively. In contrast to its high affinity (K-d similar to 2 mu
M) and active holoenzyme complex, cAMP binds to the apoenzyme nonproductiv
ely with a reduced affinity (K-d similar to 170 mu M). These results demons
trate that cofactor binding to PDE4 is responsible for eliciting its high-a
ffinity interaction with cAMP and the activation of catalysis.